International Oncology Cancer Institute

What International Oncology Cancer Institute does

International Oncology Cancer Institute (IOCI) is a privately held, for-profit network of cancer hospitals headquartered in Noida, India, that operates nine oncology centers across North, West, Central and Northeast India. The company uses an asset-light "host-hospital" model, embedding its oncology programs inside established multi-specialty hospitals — Fortis (Noida), Dr L. H. Hiranandani (Mumbai), CHL (Indore), ILS (Agartala), Seth Nandlal Dhoot (Aurangabad), Fortune (Kanpur) — rather than building standalone facilities, which allows rapid geographic expansion with limited real-estate and infrastructure capex.

Its service portfolio spans the full cancer care continuum: radiation oncology delivered via TrueBeam linear accelerators, medical oncology (chemotherapy, targeted therapy, immunotherapy, hormone therapy), surgical oncology including minimally invasive cancer surgery, hemato-oncology and bone marrow transplant services, advanced diagnostics (PET scan at Indore and Agartala, pathology, radiology, molecular biology), and supportive services such as palliative care, integrative medicine/yoga and nutritional counselling. The company reports a 15-year legacy (founded circa 2011) and positions itself as one of the fastest-growing cancer hospital chains in India.

IOCI differentiates through an AI-enabled clinical stack layered over a biweekly International Tumor Board. AI applications cover computer vision for mammography, CT, MRI and whole-slide pathology; predictive analytics for recurrence, toxicity and readmission; auto-contouring for radiotherapy planning; NLP for unstructured clinical records; knowledge retrieval that cross-references full genomic profiles against clinical trial, drug-label and literature databases in seconds; and recommendation engines matching patients to targeted therapies such as EGFR, ALK, ROS1, RET and trial options. Revenue is generated predominantly through fee-for-service oncology care (consultations, diagnostics, chemotherapy, radiotherapy, surgery and supportive services) on a quote-based, non-publicly-disclosed pricing model. Customer acquisition relies on enterprise field sales via direct hospital visits, referrals, free second opinion consultations and dedicated international patient services that bundle visa, travel and translation support for inbound medical tourism. The company is founder-and-management-controlled; the only disclosed funding round is a July 2012 investment from Rajasthan Venture Capital Fund ($3.67M), and revenue, headcount growth rates and same-center KPIs are not publicly disclosed.

Name

International Oncology Cancer Institute

Legal name

International Oncology Cancer Institute

Website

https://iociindia.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Short description

International Oncology Cancer Institute (IOCI) operates a nine-hospital cancer care network across India through host-hospital partnerships, delivering radiation, medical, surgical and hemato-oncology services with AI-assisted diagnostics and an International Tumor Board to domestic and international cancer patients.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Cancer hospital services
• Oncology treatment services
• Radiation therapy services
• Cancer diagnostic imaging
• Hematology oncology care

Headquarters

HQ city

Noida

HQ country

India

HQ region

Asia

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Healthcare Services Revenue: Revenue generated from direct patient care services including consultations, diagnostic testing, chemotherapy, radiation therapy, surgical oncology, and related cancer treatments across their hospital network.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

International Oncology Cancer Institute (IOCI) operates a network of cancer hospitals across India providing comprehensive oncology care, including medical oncology, surgical oncology, radiation oncology (using TrueBeam technology), hemato oncology, diagnostic testing (PET scan, pathology), palliative care, integrative medicine, and nutritional counselling. The company leverages AI-assisted diagnostics and an International Tumor Board to deliver personalized multidisciplinary treatment plans to cancer patients.

Product overview

International Oncology Cancer Institute (IOCI) is a network of nine cancer hospitals across India offering comprehensive oncology care through a platform of eight integrated treatment and supportive care services. The core treatment offerings include Radiation Oncology (using TrueBeam technology), Medical Oncology, Surgical Oncology, and Hemato Oncology. These are supported by Diagnostic Testing services (including PET scan at select locations), and supportive care services including Palliative Care, Integrative Medicine (Yoga), and Diet and Nutritional Counselling. The institute differentiates itself through advanced technology (TrueBeam radiation, AI-powered diagnostics), multidisciplinary care (International Tumor Board), remote expert access (Second Opinion Service), and a 15-year legacy of serving patients across its nationwide hospital network. The network includes locations in Noida, Mumbai, Aurangabad, Jodhpur, Kanpur, Saharanpur, Greater Noida, Indore, and Agartala.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiation Oncology Radiation therapy treatment using advanced technologies including TrueBeam for precise cancer treatment delivery.
• Medical Oncology Systemic treatment modality for cancer including chemotherapy, targeted therapy, immunotherapy, and hormone therapy.
• Surgical Oncology Surgical intervention for cancer treatment including minimally invasive cancer surgery.
• Hemato Oncology Treatment of blood cancers and bone marrow transplant services.
• Diagnostic Testing Advanced diagnostic facilities including PET scan, pathology, radiology, and molecular biology testing for accurate cancer diagnosis and staging.
• Palliative Care Quality of life improvement services for patients with critical or life-threatening cancer, including pain management, psychological support, and spiritual care.
• Integrative Medicine - Yoga Complementary therapy combining meditation, breathing exercises, and yoga postures to improve quality of life, emotional well-being, and reduce treatment side effects.
• Diet and Nutritional Counselling Individualized nutrition planning based on cancer stage, treatment, and preferences to maintain healthy weight, support immune function, and maximize quality of life.
• Second Opinion Service Remote expert consultation service allowing patients to receive specialist oncologist review of AI-flagged findings and treatment recommendations.
• International Tumor Board Biweekly multidisciplinary team review meeting where leading oncologists collaborate to craft patient treatment plans using AI-assisted genomic data.
• PET Scan Imaging Advanced nuclear medicine imaging technology available at select centers (Agartala and Indore) for cancer staging and treatment response assessment.
• TrueBeam Radiation Therapy Advanced linear accelerator technology for precise radiation treatment delivery, integrated with AI-assisted treatment planning.

Quantifiable outcome

• Five-year survival rate for Stage 1 breast cancer above 95%
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• ILS Hospital (Agartala)coreOthersIOCI Agartala operates within ILS Hospital, providing advanced oncology services at this multispecialty facility. The partnership enables access to existing hospital infrastructure including the region's first PET scan facility.
• CHL Hospital (Indore)coreOthersIOCI Indore is located within CHL Hospital 114, providing comprehensive cancer care using the hospital's existing infrastructure and specialist support services.
• Fortis Hospital (Noida)coreOthersIOCI Noida operates within Fortis Hospital B-22, leveraging the hospital's multispecialty infrastructure to deliver integrated cancer care services.
• Dr L. H. Hiranandani Hospital (Mumbai)coreOthersIOCI Mumbai is located within Dr L. H. Hiranandani Hospital in Powai, providing oncology services as part of the hospital's comprehensive healthcare offerings.

Scale indicators3 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• HealthCare Global Enterprises (HCG): India's largest dedicated cancer hospital chain, operating ~20+ cancer centers nationwide. HCG is the closest direct peer — same focus on oncology-only networks, similar multi-city footprint, and comparable technology-led positioning.
• American Oncology Institute (AOI): Multi-center cancer hospital network in India with a hub-and-spoke model across multiple states. Closely comparable in scale (~10 centers), specialty focus, and use of multidisciplinary tumor boards.
• Cytecare Cancer Hospitals: Specialty cancer hospital chain in India focused on organ-specific oncology programs with multidisciplinary care. Comparable as a dedicated, technology-forward cancer hospital operator.

Broad incumbents

• Medanta - The Medicity: Multi-specialty hospital chain with a dedicated Cancer Institute offering radiation, medical, and surgical oncology. Comparable on technology stack (TrueBeam-equivalent, AI imaging) and tertiary cancer care positioning.
• Tata Memorial Hospital: India's premier government cancer hospital and research center. Sets the clinical benchmark for oncology outcomes in India and is a major referral destination, competing for complex cases.
• Narayana Health (Mazumdar Shaw Medical Centre): Large multi-specialty hospital group with a strong oncology and surgical oncology footprint. Competes for complex cancer cases and offers comparable advanced diagnostics.
• Fortis Healthcare: Major multi-specialty hospital chain in India. IOCI's Noida center is co-located inside Fortis; Fortis also operates its own oncology programs, making it both a partner and a competitor.
• Max Healthcare: Large multi-specialty hospital chain with dedicated cancer care programs across North India. Overlaps geographically with IOCI's North India footprint and competes for the same patient pool.
• Apollo Hospitals (Apollo Cancer Centres): India's largest hospital chain with dedicated Apollo Cancer Centres across multiple cities. Overlaps on cancer care delivery but operates as part of a broader multi-specialty portfolio with much larger scale and capital.

Regional players

• Basavatarakam Indo American Cancer Hospital: Major standalone cancer hospital in Hyderabad focused exclusively on oncology. Comparable as a specialty cancer hospital but concentrated in a single geography rather than a multi-state network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=joStLf2_6ME
• Xx.com/IOCI_India
• Facebookfacebook.com/IOCIIndia
• LinkedInlinkedin.com/company/ioci-india

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Oncology Cancer Institute